KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) FCF Margin (2018 - 2025)

Historic FCF Margin for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to 86.61%.

  • Moderna's FCF Margin rose 56000.0% to 86.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 118.86%, marking a year-over-year decrease of 399900.0%. This contributed to the annual value of 125.31% for FY2024, which is 694500.0% down from last year.
  • Latest data reveals that Moderna reported FCF Margin of 86.61% as of Q3 2025, which was up 56000.0% from 649.3% recorded in Q2 2025.
  • In the past 5 years, Moderna's FCF Margin registered a high of 151.57% during Q1 2021, and its lowest value of 1068.52% during Q1 2025.
  • Moreover, its 5-year median value for FCF Margin was 4.57% (2022), whereas its average is 181.72%.
  • In the last 5 years, Moderna's FCF Margin surged by 15640700bps in 2021 and then crashed by -6377200bps in 2024.
  • Over the past 5 years, Moderna's FCF Margin (Quarter) stood at 44.24% in 2021, then crashed by -30bps to 30.88% in 2022, then plummeted by -54bps to 14.3% in 2023, then skyrocketed by 119bps to 31.37% in 2024, then plummeted by -376bps to 86.61% in 2025.
  • Its FCF Margin was 86.61% in Q3 2025, compared to 649.3% in Q2 2025 and 1068.52% in Q1 2025.